t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: A review of 23 cases

Cancer Genetics and Cytogenetics

Volumn 94, Issue 1, 1997, Pages 36-43

  Michaux, Lucienne ^a   Dierlamm, Judith ^c   Wlodarska, Iwona ^c   Bours, Vincent ^c   Van Den Berghe, Herman ^c   Hagemeijer, Anne ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b CENTER FOR HUMAN GENETICS   (Belgium)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

B CELL LYMPHOMA; CARCINOGENESIS; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 19; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; GENE LOCUS; HUMAN; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0030971430     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00247-6     Document Type: Article

References (49)

1. Dalla Favera R, Begni M, Erikson J, Patterson D, Gallo RC, Croce CM (1982): Human c-myc oncogene is located in the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 79:7824.
2. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM (1984): Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 2276:1097-1099.
3. Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM (1984): Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 224:1403-1424.
4. Bloomfield CD, Arthur DC, Frizzera G, Levine EG, Peterson BA, Gajl-Peczalska KJ (1983): Nonrandom chromosome abnormalities in lymphoma. Cancer Res 43:2975-2984.
5. Ueshima Y, Bird ML, Vardiman W, Rowley JD (1985): A 14;19 translocation in B-cell chronic lymphocytic leukemia: A new recurring chromosome aberration. Int J Cancer 36:287-290.
6. McKeithan T, Rowley J, Shows T, Diaz M (1987): Cloning of the chromosome translocation breakpoint junction of the t(14;19) in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 84:9257-9260.
7. Clark H, Jones D, Wright D (1992): Cytogenetic and molecular studies of t(14;18) and t(14;19) in nodal and extranodal B-cell lymphoma. J Pathol 166:129-137.
8. Asou H, Takechi M, Tanaka K, Tashiro S, Dohy H, Ohno R, Kamada N (1993): Japanese B cell chronic lymphocytic leukaemia: a cytogenetic and molecular biological study. Br J Haematol 85:492-497.
9. Michaux L, Mecucci C, Stul M, Wlodarska I, Hernandez JM, Meeus P, Michaux JL, Scheiff JM, Louwagie A, Criel A, Boogaerts M, Van Orshoven A, Cassiman JJ, Van den Berghe H (1996): BCL-3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders. Genes Chromosom Cancer 15:38-47.
10. Raghoebier S, van Krieken J, Kluin-Nelemans J, Gillis A, van Ommen G, Ginsberg A, Raffeld M, Kluin Ph (1991): Oncogene rearrangements in chronic B-cell leukemia. Blood 7:1560-1564.
11. van Krieken JHJM, McKeithan TW, Raghoebier S, Medeiros LJ, Kluin PM, Raffeld M (1990): Chromosomal translocation t(14;19) as indicated by bcl-3 rearrangement is a rare phenomenon in non-Hodgkin's lymphoma and chronic lymphocytic leukemia: a molecular genetic analysis of 176 cases. Leukemia 4:811-812.
12. Yabumoto K, Ohno H, Doi S, Edamura S, Arita Y, Akasaka T, Matsumoto J, Kadowaki N, Fukuhara S, Okuma M (1994): Involvement of the BCL3 gene in two patients with chronic lymphocytic leukemia. Int J Hematol 59:211-218.
13. Bird ML, Ueshima Y, Rowley JD, Haren JM, Vardiman JW (1989): Chromosome abnormalities in B cell chronic lymphocytic leukemia and their clinical correlations. Leukemia 3:182-191.
14. Rai KR, Sawitsky A, Cronckite EP, Chanana AD, Levy RN, Pasternack BS (1975): Clinical staging of chronic lymphocytic leukemia. Blood 46:219.
15. The Non-Hodgkin's Lymphoma Pathologic Classification Project (1982): National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a Working Formulation for clinical usage. The non-Hodgkin's lymphoma pathologic classification project. Cancer 49:2112.
16. Anastasi J, Le Beau MM, Vardiman JW, Fernald AA, Larson RA, Rowley JD (1992): Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. Blood 79:1796-1801.
17. Döhner H, Pohl S, Bulgay-Mörschel M, Stilgenbauer S, Bentz M, Lichter P (1993): Trisomy 12 in chronic lymphoid leukemias - a metaphase and interphase cytogenetic analysis. Leukemia 7:516-520.
18. Que TH, Marco JC, Ellis J, Matutes E, Brito Babapulle V, Boyle S, Catovsky D (1993): Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: Analysis by stage, immunophenotype, and morphology. Blood 82:571-575.
19. Escudier SM, Pereira-Leahy JM, Drach JW, Weier HU, Goodacre AM, Cork MA, Trujillo JM, Keating MJ, Andreeff M (1993): Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia. Blood 81:2702-2707.
20. García-Marco J, Matutes E, Morilla R, Ellis J, Oscier D, Fantes J, Catovsky D, Price CM (1994): Trisomy 12 in B-cell chronic lymphocytic leukaemia: assessment of lineage restriction by simultaneous analysis of immunophenotype and genotype in interphase cells by fluorescence in situ hybridization. Br J Haematol 87:44-50.
21. Matutes E, Oscier D, Garcia-Marco J, Ellis J, Copplestone A, Gillingham R, Hamblin T, Lens D, Swansbury GJ, Catovsky D (1996): Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 92:382-388.
22. Knauf WU, Knuutila S, Zeigmeister B, Thiel E (1995): Trisomy 12 in B-cell chronic lymphocytic leukemia: correlation with advanced disease, atypical morphology, high levels of sCD25, and with refractoriness to treatment. Leukemia Lymphoma 19:289-294.
23. Hernandez JM, Mecucci C, Criel A, Meeus P, Michaux L, Van Hoof A, Verhoef G, Louwagie A, Scheiff J-M, Michaux J-L, Boogaerts M, Van den Berghe H (1995): Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria. Leukemia 9:2140-2146.
24. Criel A, Wlodarska I, Meeus P, Stul M, Louwagie A, Van Hoof A, Hidajat M, Mecucci C, Van den Berghe H (1994): Trisomy 12 is uncommon in typical chronic lymphocytic leukaemias. Brit J Haematol 87:523-528.
25. McKeithan T, Ohno H, Diaz M (1990): Identification of a transcriptional unit adjacent to the breakpoint in the 14;19 translocation of chronic lymphocytic leukemia. Genes Chromosom Cancer 1:247-255.
26. Ohno H, Doi S, Yabumoto K, Fukuhara S, McKeithan T (1993): Molecular characterization of the t(14;19)(q32;q13) translocation in chronic lymphocytic leukemia. Leukemia 7:2057-2063.
27. Grossen PE, Godwin JM, Heaton DC, Tully SM (1987): Chromosome abnormalities in chronic lymphocytic leukemia revealed by cytochalasin B and Epstein-Barr virus. Cancer Genet Cytogenet 28:93-100.
28. McKeithan TW, Ohno H, Dickstetin J, Hume E (1994): Genomic structure of the candidate protooncogene BCL3. Genomics 24:120-126.
29. Fujita I, Nolan GP, Lion H, Scott ML, Baltimore D (1993): The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev 7:1354-1363.
30. Siebenlist U, Franzoso G, Brown K (1994): Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10:405-455.
31. Baeuerle PA, Henkel T (1994): Function and activation of NF-κB in the immune system. Annu Rev Immunl 12:141-179.
32. Ohno H, Takimoto G, McKeithan T (1990): The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60:991-997.
33. Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, Siebenlist U (1993): The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell 72:729-739.
34. Franzoso G, Bours V, Azarenko V, Park S (1993): The oncoprotein bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. Embo J 12:3893-3901.
35. Nolan GP, Baltimore D (1992): The inhibitory ankyrin and activator Rel protein. Curr Opin Genet Deve 2:211-220.
36. Neri A, Chang c-C, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RSK, Dalla-Favera R (1991): B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell 67:1075-1087.
37. Fracchiolla NS, Lombardi L, Salina M, Migliazza KA, Baldini L, Berti E, Cro L, Polli E, Maiolo AT, Neri A (1993): Structural alterations of NF-κB transcription factor lyt-10 in lymphoid malignancies. Oncogene 8:2839-2845.
38. Miggliazza A, Lombardi L, Rocchi M, Trecca D, Chang C-C, Antonacci R, Fracchiolla NS, Ciana P, Maiolo AT, Neri A (1994): Heterogeneous chromosomal aberrations generate 3′ truncations of the NFKB2/lyt-10 gene in lymphoid malignancies. Blood 84:3850-3860.
39. Chang C-C, Zhang J, Lombardi L, Neri A, Dalla-Favera R (1995): Rearranged NFKB-2 gene in lymphoid neoplasms code for constitutively active nuclear transactivators. Mol Cell Biol 15:5180-5187.
40. Taniwak, Matsuda F, Jauch A, Nishida K, Takashima T, Tagawa S, Sugiyama H, Misawa S, Abe T, Kashima K (1994): Detection of 14q32 translocations in B-cell malignancies by in situ hybridization with yeast artificial chromosome clones containing the human IgH gene locus. Blood 83:2962-2969.
41. Speaks SL, Sanger WG, Linder J, Johnson DR, Armitage JO, Weisenburger D, Purtilo D (1987): Chromosomal abnormalities in indolent lymphoma. Cancer Genet Cytogenet 27:335-344.
42. Crossen PE, Kennedy MA, Heaton DC, Morrison MJ (1993): Cloning and sequencing of a t(14;19) breakpoint that involves the Cμ switch region. Genes Chromosom Cancer 8:60-62.
43. Koduru PRK, Lichtman SM, Smilari TF, Sun T, Gh JC, Karp L, Hall W, Hashimoto S, Chiorazzi N, Broome JD (1993): Serial phenotypic, cytogenetic and molecular genetic studies in Richter's syndrome: demonstration of lymphoma development from the chronic lymphocytic leukaemia cells. Br J Haematol 85:613-616.
44. Busschots AM, Mecucci C, Stul M, Vandenberg E, Michaux JL, Noël H, Cassiman JJ, Van den Berghe H (1991): Translocation (14;19)(q32.q13.1) in a young patient who developed a large cell lymphoma after an initial diagnosis of CLL. Leukemia Lymphoma 5:281-286.
45. Solé F, Woessner S. Florensa L, Perez-Losada A, Bonet C, Besses C (1994): A new case of t(14;19)(q32;q13) in a patient with follicular lymphoma in leukemic phase. Cancer Genet Cytogenet 75:72-73.
46. Tanaka S, Nishigaki H, Kakagawa H, Okuda T, Nishida K, Tsuda S, Taniwaki M, Imanishi H, Misawa S, Kashima K, Urata Y, Inazawa J, Abe T, McKeithan TW (1990): Reciprocal t(14;19)(q32.3;q13.1) in a patient with B-cell lymphoma. Cancer Genet Cytogenet 49:219-224.
47. Carter R, Dubé I, McKeithan T, Carstairs K, DeHarven E, Bailey D, Scott JG (1991): Translocation (14;19) in acute biphenotypic leukemia. Cancer Genet Cytogenet 53:67-73,
48. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillot C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F (1981): A new prognostic classification of chronic lymphocytic leukemia derived from multivariate survival analysis. Cancer 48:198.
49. ISCN (1995): Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Mitelman F. (ed). Karger, Basel.